Granulomatous anterior uveitis following mRNA-based COVID-19 vaccination: A case report

Granulomatous anterior uveitis following mRNA-based COVID-19 vaccination: A case report

A 23-year-old patient presented with complaints of redness, pain, photophobia, and blurred vision in the right eye 15 days after she received the third dose of BNT162b2 vaccination. Ocular examination revealed 2+ cellular reactions in the anterior chamber and mutton fat keratic precipitate with no v...

Full description

Bibliographic Details
Main Authors:	Furkan Cam, Gizem Gok, Hande Celiker
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Indian Journal of Ophthalmology
Subjects:	bnt162b2 covid-19 covid-19 vaccine granulomatous anterior uveitis mutton fat keratic precipitate
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=3;spage=1033;epage=1035;aulast=Cam

Similar Items

Confocal Scan Features of Keratic Precipitates in Granulomatous versus Nongranulomatous Uveitis
by: Mozhgan Rezaei Kanavi, et al.
Published: (2011-01-01)

Acute anterior non-granulomatous uveitis in COVID-19—A case series
by: Priyadarshini Parthasarathi, et al.
Published: (2023-01-01)

Granulomatous Features in Juvenile Idiopathic Arthritis-Associated Uveitis is Not a Rare Occurrence
by: Papasavvas I, et al.
Published: (2021-03-01)

Clinical Features and Prognosis of Herpetic Anterior Uveitis
by: Esra Kardeş, et al.
Published: (2016-06-01)

Bilateral Conjunctivitis, Keratitis, and Anterior Uveitis in a Patient Co-infected with Parvovirus B19 and SARS-CoV-2
by: Maria Carmela Saturno, et al.
Published: (2022-11-01)

Granulomatous Anterior Uveitis, Internal Ophthalmoplegia, and Retinal Vasculitis During Chickenpox Disease in A Child
by: Meryem Donbaloğlu, et al.
Published: (2013-10-01)

Efficacy of subtenon steroid injection alone or in combination with topical steroid in the management of trematode-induced anterior granulomatous uveitis
by: Marwa Aly Zaky, et al.
Published: (2023-01-01)

Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines
by: Cynthia M. Rohde, et al.
Published: (2023-02-01)

COVID-19 vaccination and recurrent anterior uveitis
by: Srinivasan Sanjay, et al.
Published: (2022-01-01)

IgG4-related hypertensive granulomatous anterior uveitis
by: Judy L. Chen, et al.
Published: (2022-06-01)

An analysis of the clinical profile of patients with uveitis following COVID-19 infection
by: Sudha K Ganesh, et al.
Published: (2022-01-01)

Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence?
by: Giulia Renisi, et al.
Published: (2021-09-01)

A case of adult-onset tubulointerstitial nephritis and uveitis syndrome presenting with granulomatous panuveitis
by: Kemal Tekin, et al.
Published: (2020-01-01)

Sarcoidosis developing after COVID‐19: A case report
by: Dujrath Somboonviboon, et al.
Published: (2022-09-01)

Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine
by: Hiroaki Akiyama, et al.
Published: (2021-01-01)

Anterior Uveitis Caused by Ocular Side Effects of Afatinib: A Case Report
by: Daisuke Todokoro, et al.
Published: (2016-02-01)

Reduced Antibody Acquisition with Increasing Age following Vaccination with BNT162b2: Results from Two Longitudinal Cohort Studies in The Netherlands
by: Lotus Leonie van den Hoogen, et al.
Published: (2022-09-01)

Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine
by: Itzchak Levy, et al.
Published: (2022-07-01)

Surgical outcomes of complicated cataract with pediatric trematode granulomatous uveitis
by: Mahmoud M. Farouk, et al.
Published: (2023-03-01)

Evaluation of the QuantiFERON SARS-CoV-2 assay to assess cellular immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in individuals with low and high humoral response
by: Areti Tychala, et al.
Published: (2021-12-01)

Acute Anterior Uveitis (Ocular Manifestation of COVID-19): A Case Report
by: Tayyaba Gul Malik
Published: (2021-04-01)

COVID-19 vaccination, dengue hepatitis, and recurrent unilateral anterior uveitis
by: Srinivasan Sanjay, et al.
Published: (2023-01-01)

Rheumatoid polyarthritis suspected in an HIV patient with scleritis, peripheral ulcerative keratitis, and anterior uveitis
by: Domngang Noche C, et al.
Published: (2016-02-01)

Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis
by: Eli Magen, et al.
Published: (2022-07-01)

Geomapping of trematode-induced granulomatous anterior uveitis - a newly identified cause of blindness among children in the Pudukkottai district of the Tamil Nadu State, India
by: Jayakumar Duraisamy, et al.
Published: (2009-11-01)

Pulmonary Embolism after Vaccination with the COVID-19 Vaccine (Pfizer, BNT162b2): A Case Report
by: Eun-Ju Kim, et al.
Published: (2023-06-01)

Serological response to a third booster dose of BNT162b2 COVID‐19 vaccine among seronegative cancer patients
by: Einat Shacham Shmueli, et al.
Published: (2022-08-01)

Granulomatous Keratitis following Corneal Tattooing.
by: Sharma Ashok, et al.
Published: (2003-01-01)

Significant Increase in Blood Pressure Following BNT162b2 mRNA COVID-19 Vaccination among Healthcare Workers: A Rare Event
by: Nikolaos Syrigos, et al.
Published: (2022-05-01)

Corneal Edema with Anterior Uveitis after Exposure to the Sap of Euphorbia trigona: A Case Report
by: Takashi Ono, et al.
Published: (2021-08-01)

Safety and Immunogenicity of a Single Dose of BNT162b2 COVID-19 mRNA Vaccine in a Warfarin-Treated Protein S Deficient Patient: A Case Report and Literature Review
by: Cucunawangsih Cucunawangsih, et al.
Published: (2022-12-01)

Current approach in diagnosis and management of anterior uveitis
by: Agrawal Rupesh, et al.
Published: (2010-01-01)

Effectiveness of BNT162b2 COVID-19 Vaccine in Preventing Severe Symptomatic Infection among Healthcare Workers
by: Efrén Murillo-Zamora, et al.
Published: (2021-07-01)

Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseases
by: Michael Kwan Leung Yu, et al.
Published: (2023-01-01)

Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns
by: Matteo Nioi, et al.
Published: (2021-11-01)

Effect of SARS-CoV-2 Infection and BNT162b2 Vaccination on the mRNA Expression of Genes Associated with Angiogenesis
by: Paulina Wigner-Jeziorska, et al.
Published: (2023-11-01)

The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation
by: Marika Watanabe, et al.
Published: (2022-01-01)

BNT162b2, mRNA-1273, and Sputnik V Vaccines Induce Comparable Immune Responses on a Par With Severe Course of COVID-19
by: Anna Kaznadzey, et al.
Published: (2022-04-01)

Risk of herpes zoster following mRNA COVID-19 vaccine administration
by: Ana Florea, et al.
Published: (2023-12-01)

SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naïve and previously infected individuals
by: Andrea Lombardi, et al.
Published: (2021-08-01)